Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study

Saved in:
Bibliographic Details
Published in:Hepatic Medicine: Evidence and Research
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553002638376960
collection WordPress RSS
FRELIP Feed Integration
container_title Hepatic Medicine: Evidence and Research
description
discipline_display Gastroenterology and Hepatology
discipline_facet Gastroenterology and Hepatology
format Online Article
RSS Article
genre Journal Article
id rss_article:71221
institution FRELIP
journal_source_facet Hepatic Medicine: Evidence and Research
last_indexed 2026-06-20T21:29:57.061Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
Gastroenterology and Hepatology
General
Gastroenterology and Hepatology
sub_discipline_display General
sub_discipline_facet General
subject_display Gastroenterology and Hepatology
General
Gastroenterology and Hepatology
subject_facet Gastroenterology and Hepatology
General
Gastroenterology and Hepatology
title The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_alt El efecto de Liv.52 DS en la enfermedad del hígado graso asociada a disfunción metabólica (MAFLD): un estudio clínico piloto, aleatorizado, doble ciego, controlado con placebo
Effet de Liv.52 DS dans la stéatose hépatique associée à un dysfonctionnement métabolique (MAFLD) : une étude clinique pilote, randomisée, en double aveugle, contrôlée par placebo
O efeito do Liv.52 DS na doença hepática gordurosa associada à disfunção metabólica (MAFLD): um estudo clínico piloto, randomizado, duplo-cego, controlado por placebo
title_auth The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_es_txt El efecto de Liv.52 DS en la enfermedad del hígado graso asociada a disfunción metabólica (MAFLD): un estudio clínico piloto, aleatorizado, doble ciego, controlado con placebo
title_fr_txt Effet de Liv.52 DS dans la stéatose hépatique associée à un dysfonctionnement métabolique (MAFLD) : une étude clinique pilote, randomisée, en double aveugle, contrôlée par placebo
title_full The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_fullStr The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_full_unstemmed The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_pt_txt O efeito do Liv.52 DS na doença hepática gordurosa associada à disfunção metabólica (MAFLD): um estudo clínico piloto, randomizado, duplo-cego, controlado por placebo
title_short The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
title_sort the effect of liv.52 ds in metabolic dysfunction-associated fatty liver disease (mafld): a pilot, randomized, double-blind, placebo-controlled, clinical study
topic Gastroenterology and Hepatology
General
Gastroenterology and Hepatology
url https://www.dovepress.com/the-effect-of-liv52-ds-in-metabolic-dysfunction-associated-fatty-liver-peer-reviewed-fulltext-article-HMER